HomeOwner SearchCategory Search
Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response
Visit USCO
hero image
Text Registration
Copyright Title

Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response

Status

Published

on 27 Sept 2016
Year of Creation
2016
Copyright Claimant
Zuzana Jirina Berrong
Registration Number
TX0008273801
on 27 Sept 2016

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008273801) dated 27 Sept 2016, pertains to an electronic file (eService) titled "Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response" created in 2016. The copyright holder is Zuzana Jirina Berrong, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Zuzana Jirina Berrong.

Copyright Details


Copyright Claimant
Zuzana Jirina Berrong

Application Details


Registration Number
TX0008273801
Registration Date
9/27/2016
Year of Creation
2016
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Electronic file (eService)
First Publication Nation
United States

Personal Authors


Notes


Rights Note: Diana G Zajic, ProQuest-CSA, LLC, 789 E. Eisenhower Parkway, Ann Arbor, MI, 48108-3218, United States, (800) 521-0600 xext77020, disspub@proquest.com

Statements


Application Title Statement: Combinational immunotherapy of anti-OX40 antibody and IDO inhibitor synergistically enhances anti-tumor immune T cell-mediated response
Author Statement: Zuzana Jirina Berrong Citizenship: Czech Republic Authorship: text
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions